We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CPIX market cap is 35.81M. The company's latest EPS is USD -0.4471 and P/E is -5.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.09M | 9.35M | 8.5M | 9.85M | 9.09M |
| Operating Income | -1.87M | -6.18M | -1.87M | -1.03M | -1.7M |
| Net Income | -1.05M | -6.29M | -1.95M | -1.09M | -1.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 47.53M | 37.44M | 35.99M | 42.01M | 39.55M |
| Operating Income | -3.62M | -6.38M | -7.68M | -5.71M | -9.56M |
| Net Income | -3.54M | -3.34M | -3.51M | -5.57M | -6.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 87.75M | 81.78M | 81.51M | 78.52M | 76.75M |
| Total Liabilities | 52.1M | 52.52M | 54.32M | 52.49M | 52.28M |
| Total Equity | 35.66M | 29.26M | 27.19M | 26.03M | 24.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 104.55M | 96.46M | 84.46M | 92.93M | 81.78M |
| Total Liabilities | 53.46M | 49.59M | 41.86M | 56.95M | 52.52M |
| Total Equity | 51.09M | 46.87M | 42.6M | 35.97M | 29.26M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.05M | 6.09M | -2.14M | -2.99M | -2.52M |
| Investing | -367k | -106k | -59k | -105k | 85k |
| Financing | -5.94M | -7.42M | 2.42M | 2.11M | 1.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 3.06M | 5.42M | 6.34M | 8.45M | 6.09M |
| Investing | 2.3M | -1.76M | -502k | -13.67M | -106k |
| Financing | -5.08M | -7.12M | -3.55M | -2.06M | -7.42M |
| Market Cap | 35.81M |
| Price to Earnings Ratio | -5.66 |
| Price to Sales Ratio | 0.9 |
| Price to Cash Ratio | 1.94 |
| Price to Book Ratio | 1.21 |
| Dividend Yield | - |
| Shares Outstanding | 14.04M |
| Average Volume (1 week) | 1.61M |
| Average Volume (1 Month) | 558.63k |
| 52 Week Change | 30.10% |
| 52 Week High | 3.93 |
| 52 Week Low | 1.04 |
| Spread (Intraday) | 2.36 (69.41%) |
| Company Name | Cumberland Pharmaceutical Inc |
| Address |
2525 west end avenue nashville, tennessee 37203 |
| Website | https://www.cumberlandpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
